Virtus ETF Advisers’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $68K | Sell |
|
|||||
|
2024
Q3 | $121K | Buy |
|
|||||
|
2024
Q2 | $91.3K | Sell |
|
|||||
|
2024
Q1 | $121K | Sell |
|
|||||
|
2023
Q4 | $102K | Buy |
|
|||||
|
2023
Q3 | $57.4K | Sell |
|
|||||
|
2023
Q2 | $105K | Sell |
|
|||||
|
2023
Q1 | $237K | Sell |
|
|||||
|
2022
Q4 | $155K | Sell |
|
|||||
|
2022
Q3 | $120K | Buy |
|
|||||
|
2022
Q2 | $112K | Buy |
|
|||||
|
2022
Q1 | $124K | Sell |
|
|||||
|
2021
Q4 | $189K | Buy |
|
|||||
|
2021
Q3 | $92K | Sell |
|
|||||
|
2021
Q2 | $244K | Sell |
|
|||||
|
2021
Q1 | $372K | Buy |
|
|||||
|
2020
Q4 | $284K | Sell |
|
|||||
|
2020
Q3 | $372K | Sell |
|
|||||
|
2020
Q2 | $382K | Buy |
|